These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33979529)

  • 1. Online Marketing of
    Lai S; Yu C; Dennehy CE; Tsourounis C; Lee KP
    J Altern Complement Med; 2021 Sep; 27(9):796-802. PubMed ID: 33979529
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.
    Haller CA; Duan M; Benowitz NL; Jacob P
    J Anal Toxicol; 2004 Apr; 28(3):145-51. PubMed ID: 15107143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of ephedra-free labeled dietary supplements sold in the San Francisco Bay area in 2003.
    Tam JW; Dennehy CE; Ko R; Tsourounis C
    J Herb Pharmacother; 2006; 6(2):1-19. PubMed ID: 17182481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content versus label claims in ephedra-containing dietary supplements.
    Gurley BJ; Gardner SF; Hubbard MA
    Am J Health Syst Pharm; 2000 May; 57(10):963-9. PubMed ID: 10832496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography.
    Gurley BJ; Wang P; Gardner SF
    J Pharm Sci; 1998 Dec; 87(12):1547-53. PubMed ID: 10189265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
    Haller CA; Benowitz NL
    N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of internet websites marketing herbal weight-loss supplements to consumers.
    Jordan MA; Haywood T
    J Altern Complement Med; 2007 Nov; 13(9):1035-43. PubMed ID: 18047451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of Internet marketing of products that contain ephedra.
    Ashar BH; Miller RG; Getz KJ; Pichard CP
    Mayo Clin Proc; 2003 Aug; 78(8):944-6. PubMed ID: 12911041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of ephedrine alkaloids in botanicals and dietary supplements by HPLC-UV: collaborative study.
    Roman MC
    J AOAC Int; 2004; 87(1):1-14. PubMed ID: 15084081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.
    Gurley BJ; Steelman SC; Thomas SL
    Clin Ther; 2015 Feb; 37(2):275-301. PubMed ID: 25262198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the stimulant content of dietary supplements marketed as "ephedra-free".
    Gregory PJ
    J Herb Pharmacother; 2007; 7(1):65-72. PubMed ID: 17594988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS; Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.
    Miller SC
    Mil Med; 2004 Feb; 169(2):87-93. PubMed ID: 15040625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
    JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Banned and discouraged-use ingredients found in weight loss supplements.
    Eichner S; Maguire M; Shea LA; Fete MG
    J Am Pharm Assoc (2003); 2016; 56(5):538-43. PubMed ID: 27475836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenicity of weight-loss supplements marketed on the Internet.
    Nazeri A; Massumi A; Wilson JM; Frank CM; Bensler M; Cheng J; Saeed M; Rasekh A; Razavi M
    Heart Rhythm; 2009 May; 6(5):658-62. PubMed ID: 19328040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephedra ban: no shortage of reasons.
    Rados C
    FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of ephedra alkaloid and caffeine concentrations in dietary supplements and biological fluids.
    Jacob P; Haller CA; Duan M; Yu L; Peng M; Benowitz NL
    J Anal Toxicol; 2004 Apr; 28(3):152-9. PubMed ID: 15107144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Má Huáng.
    Betz JM; Gay ML; Mossoba MM; Adams S; Portz BS
    J AOAC Int; 1997; 80(2):303-15. PubMed ID: 9086588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.